October 2014 FDA Recall Drug by Nanophase Technologies Corporation
D-0238-2015 - cGMP Deviation; The incorrect amount of a raw material was added during the manufacture of two lots of Z-COTE HP 1.

This Class III drug recall was voluntarily initiated by Nanophase Technologies Corporation on October 20, 2014 for the product Drug. The FDA reported the reason for recall as cgmp deviation; the incorrect amount of a raw material was added during the manufacture of two lots of z-cote hp 1.. The product was distributed in NJ and the recall is currently terminated.

Recall Number: D-0238-2015

Reason for Recall
cGMP Deviation; The incorrect amount of a raw material was added during the manufacture of two lots of Z-COTE HP 1.
Initiated
10-20-2014
Reported
11-12-2014
Quantity
1,596 Kg

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Nanophase Technologies Corporation
Z-COTE HP 1 TRANSPARENT ZINC OXIDE, Zinc Oxide (and) Triethoxycaprylylsilane, Powder, NET: 22 KG, Packaged in double plastic liners in a single fiber carton, FOR MANUFACTURING, PROCESSING OR REPACKING, BASF Corporation, Florham Park, NJ

Batch or Lot Expiration Information

Lot# Lot Codes: CNNI2901, CNNI2902